Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
XTSX:TLT
Price:
0.28
CAD
-3.45%
Market Closed
Market Cap:
CA$72m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Theralase Technologies Inc
XTSX:TLT
|
CA |
|
CrowdStrike Holdings Inc
NASDAQ:CRWD
|
US |
|
S
|
Sidiz Inc
KRX:134790
|
KR |
|
Oil and Natural Gas Corporation Ltd
NSE:ONGC
|
IN |
|
NV5 Global Inc
NASDAQ:NVEE
|
US |
|
V
|
VIX Securities JSC
VN:VIX
|
VN |
|
Semtech Corp
NASDAQ:SMTC
|
US |
|
A
|
Alstom SA
XETRA:AOMD
|
FR |
|
DSM-Firmenich AG
OTC:DSFIY
|
CH |
|
MLP SE
XETRA:MLP
|
DE |
|
E
|
Evolution AB (publ)
F:E3G1
|
SE |
Balance Sheet
Balance Sheet Decomposition
Theralase Technologies Inc
Theralase Technologies Inc
Balance Sheet Decomposition is not available for
Theralase Technologies Inc
Theralase Technologies Inc
Balance Sheet
Theralase Technologies Inc
Theralase Technologies Inc
Currency: CAD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
2
|
2
|
4
|
3
|
0
|
1
|
13
|
8
|
4
|
2
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
2
|
2
|
4
|
3
|
0
|
1
|
13
|
8
|
4
|
2
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
3
|
7
|
6
|
2
|
3
|
14
|
9
|
5
|
3
|
1
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-33%
|
1
+520%
|
1
+100%
|
4
+186%
|
4
-1%
|
4
+5%
|
3
-14%
|
4
+32%
|
1
-67%
|
1
+2%
|
1
-20%
|
3
+137%
|
4
+43%
|
7
+86%
|
6
-12%
|
3
-47%
|
4
+7%
|
15
+334%
|
10
-35%
|
6
-41%
|
4
-30%
|
3
-21%
|
3
-1%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
0
|
0
|
0
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+2 100%
|
0
-18%
|
0
-11%
|
0
+94%
|
0
+10%
|
1
+132%
|
1
-11%
|
1
+1%
|
1
+35%
|
1
+25%
|
1
-23%
|
1
-45%
|
1
+54%
|
1
-30%
|
1
+132%
|
3
+101%
|
2
-37%
|
1
-47%
|
1
+2%
|
1
+22%
|
1
+28%
|
1
-14%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
3
|
3
|
3
|
4
|
6
|
6
|
7
|
7
|
8
|
6
|
7
|
8
|
9
|
14
|
20
|
23
|
25
|
26
|
42
|
42
|
42
|
45
|
46
|
49
|
|
| Retained Earnings |
5
|
5
|
5
|
5
|
5
|
5
|
6
|
8
|
7
|
9
|
10
|
12
|
12
|
15
|
18
|
22
|
29
|
31
|
35
|
43
|
48
|
53
|
57
|
64
|
|
| Additional Paid In Capital |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
10
|
11
|
11
|
12
|
18
|
|
| Total Equity |
0
N/A
|
0
-36%
|
0
+344%
|
1
+163%
|
3
+223%
|
3
-5%
|
3
+5%
|
2
-29%
|
3
+46%
|
1
-81%
|
0
-31%
|
0
N/A
|
2
N/A
|
3
+88%
|
6
+91%
|
6
-10%
|
2
-64%
|
1
-51%
|
14
+1 287%
|
9
-34%
|
5
-45%
|
3
-39%
|
2
-38%
|
2
+9%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-33%
|
1
+510%
|
1
+103%
|
4
+186%
|
4
-1%
|
4
+5%
|
3
-14%
|
4
+32%
|
1
-67%
|
1
+2%
|
1
-20%
|
3
+137%
|
4
+43%
|
7
+86%
|
6
-12%
|
3
-47%
|
4
+7%
|
15
+334%
|
10
-35%
|
6
-41%
|
4
-30%
|
3
-21%
|
3
-1%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
21
|
21
|
26
|
28
|
33
|
33
|
35
|
35
|
39
|
39
|
42
|
45
|
66
|
85
|
107
|
121
|
126
|
135
|
206
|
204
|
204
|
217
|
228
|
248
|
|
Switch to:
Switch to:
See Also
Discover More
